Israel’s Syneron Medical Ltd, a global medical aesthetic device company, this month launched a national advertising campaign it says promises to help achieve a “flatter tummy without the torture.” The multi-channel campaign developed by Healthcare Advertising agency Abelson Taylor, highlights UltraShape as a painless and viable alternative to traditional body shaping – especially for stubborn abdominal fat that is resistant to diet and exercise. Instead of completing sit-ups, the campaign highlights that consumers might drop up to two waist sizes in just three 45-minute sessions, with some visible results seen as early as two weeks.
As the first and only FDA-approved non-invasive body contouring system of its kind, UltraShape offers measurable fat reduction to the abdominal area (an average of loss of 1.3 – 2.5 inches) without the risks associated with other fat reduction procedures. Pulsed focused ultrasound energy is used to precisely and non thermally target subcutaneous fat, while keeping the surrounding tissue, blood vessels, nerves and muscles intact.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
“UltraShape uses ultrasound technology that was perfected in 10 years of research and development by world leading scientists and doctors to non-invasively destruct fat without any damage to surrounding tissue, ” states Shimon Eckhouse, Ph.D., Chairman of the Board of Directors for Syneron Candela. “UltraShape efficiency in non-invasive fat destruction has been studied and proven in more than 13 clinical studies with more than 900 patients treated by this technology. These studies have also demonstrated the excellent safety record of the technology as well as its ability to do it with no downtime to the patient. Following the FDA clearance of the technology we are very proud to bring this new and exciting technology to US patients”
Research conducted by Syneron Candela found that 72 percent of women are dissatisfied with their abdominal area. “Non-invasive body shaping is a growth driver for Syneron Candela and the aesthetic market place, ” says Amit Meridor, Chief Executive Officer of Syneron Candela. “UltraShape’s unique abilities make it extremely appealing to the increasing number of men and women seeking safe, quick, and painless ways to reduce suborn abdominal fat.”
UltraShape targets stubborn fat that doesn’t disappear with diet and exercise. Unlike liposuction, the treatment is non-surgical, which means no incisions, anesthetics or recovery time. It is painless and there is no downtime. UltraShape is an ideal ‘lunch hour’ treatment as patients can resume normal activities immediately after.
